Audio research news

But the alternatives, including living-brain biopsies, raise logistical and ethical questions, experts say.

Minimally verbal autistic preschoolers gained new words and phrases in a head-to-head comparison of two interventions.

Changes to the DSM-5's diagnostic criteria for autism were meant to add clarity, but they also generated new questions.

A careful clinician who prizes evidence, Jeremy Veenstra-VanderWeele is happy to embrace trial failures, as long as he learns from them.

The drug clemastine and other compounds that fortify the protective sheath around neurons may prove therapeutic for some genetic neurodevelopmental conditions.

These scores - composite measures of a person's autism-linked common genetic variants - cannot predict an autism diagnosis but could help researchers better understand the condition's underlying biology.

The papers were flagged by a method that has now been called into question.

Experiments offer clues to why certain mutations are associated with autism in some people and not others.

New data from clinical trials of arbaclofen and oxytocin underscore the murkiness of null results. Plus, researchers seek clarity on the neurodevelopmental effects of oxytocin during childbirth.